XML 21 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

Note 6. Stock-Based Compensation

Effective January 1, 2024, the number of shares of common stock available under the 2021 Incentive Award Plan (the “2021 Plan”) increased by 1,798,926 shares pursuant to the evergreen provision. As of September 30, 2024, 844,800 shares of common stock remained available for issuance under the 2021 Plan. Effective January 1, 2024, the number of shares of common stock available under the 2021 Employee Stock Purchase Plan (the “ESPP”) increased by 359,785 shares pursuant to the evergreen provision of the ESPP. As of September 30, 2024, 650,400 shares of common stock remained available for issuance under the ESPP. As of

September 30, 2024, 1,873,750 shares of common stock remained available for issuance under the 2023 Inducement Equity Plan as adopted in November 2023.

Stock-Based Compensation Expense

Total stock-based compensation expense related to the Company’s equity incentive plans and ESPP was recorded in the statements of operations and allocated as follows (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

 

$

2,478

 

 

$

1,778

 

 

$

7,472

 

 

$

4,902

 

General and administrative

 

 

2,264

 

 

 

1,820

 

 

 

7,132

 

 

 

5,365

 

Total stock-based compensation expense

 

$

4,742

 

 

$

3,598

 

 

$

14,604

 

 

$

10,267

 

As of September 30, 2024, there was $32.3 million of total unrecognized stock-based compensation expense which is expected to be recognized over a weighted-average period of 2.2 years.

Stock Options

The following table summarizes stock option activity:

 

 

 

Outstanding Options

 

 

 

Shares

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(Years)

 

Balance, December 31, 2023

 

 

7,357,607

 

 

$

9.34

 

 

 

8.1

 

Granted

 

 

2,212,885

 

 

 

13.27

 

 

 

 

Exercised

 

 

(106,339

)

 

 

4.86

 

 

 

 

Cancelled

 

 

(333,024

)

 

 

13.06

 

 

 

 

Balance, September 30, 2024

 

 

9,131,129

 

 

$

10.21

 

 

 

7.8

 

Exercisable, September 30, 2024

 

 

4,983,606

 

 

$

9.52

 

 

 

7.2

 

 

Restricted Stock

The following table summarizes the restricted stock activity:

 

 

 

Number of
Restricted
Stock Awards

 

 

Weighted-Average
Grant Date
Fair Value

 

Balance, December 31, 2023

 

 

111,920

 

 

$

4.06

 

Granted

 

 

 

 

 

 

Released

 

 

(104,060

)

 

 

4.04

 

Forfeited

 

 

(2,564

)

 

 

3.96

 

Balance, September 30, 2024

 

 

5,296

 

 

$

4.50